InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Canada

  • Welcome to the Canadian pharmaceutical patent dance

    Canada’s new drug and biosimilar patent linkage system will fundamentally change the nature of proceedings. J Bradley White and Nathaniel Lipkus of Osler Hoskin & Harcourt discuss key changes of interest to life sciences companies

  • Five important cases from Canada

    Michael Loney and Natalie Rahhal analyse five IP decisions issued in Canada, two from the Supreme Court and three from the Federal Court

  • Canada: The new frontier for global IP litigation

    The landscape for IP litigation has improved considerably in Canada. Kevin P Siu and Steven B Garland of Smart & Biggar outline the benefits for global rights owners


profile

Managing IP

ManagingIP

ManagingIP profile

"The recent proposal of automatically granting pending applications without examination is nothing but a desperate… https://t.co/9lE4RD00Rz

Nov 20 2017 09:17 ·  reply ·  retweet ·  favourite
ManagingIP profile

New speakers announced at our NY https://t.co/sCxge69xRz and CA https://t.co/BGVnkVWSpC European Patent Events. F… https://t.co/3MlekFfPZR

Nov 20 2017 03:33 ·  reply ·  retweet ·  favourite
ManagingIP profile

India’s Supreme Court pushes for faster IPR suits https://t.co/G0vmxWOc5g Delhi High Court has been given until mid… https://t.co/W576LiUGCF

Nov 20 2017 10:05 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements